TET2 c.1751C>T ;(p.A584V)

Variant ID: 4-106156850-C-T

NM_001127208.2(TET2):c.1751C>T;(p.A584V)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.

Diagnostics (Basel, Switzerland)
Szkukalek, Judita J; Dóczi, Róbert R; Dirner, Anna A; Boldizsár, Ákos Á; Varga, Ágnes Á; Déri, Júlia J; Lakatos, Dóra D; Tihanyi, Dóra D; Vodicska, Barbara B; Schwáb, Richárd R; Pajkos, Gábor G; Várkondi, Edit E; Vályi-Nagy, István I; Valtinyi, Dorottya D; Nagy, Zsuzsanna Z; Peták, István I
Publication Date: 2021-10-07

Variant appearance in text: TET2: 1751C>T
PubMed Link: 34679548
Variant Present in the following documents:
  • diagnostics-11-01850.pdf
View BVdb publication page



Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.

Leukemia
Bolli, Niccolo N; Biancon, Giulia G; Moarii, Matahi M; Gimondi, Silvia S; Li, Yilong Y; de Philippis, Chiara C; Maura, Francesco F; Sathiaseelan, Vijitha V; Tai, Yu-Tzu YT; Mudie, Laura L; O'Meara, Sarah S; Raine, Keiran K; Teague, Jon W JW; Butler, Adam P AP; Carniti, Cristiana C; Gerstung, Moritz M; Bagratuni, Tina T; Kastritis, Efstathios E; Dimopoulos, Meletios M; Corradini, Paolo P; Anderson, Kenneth C KC; Moreau, Philippe P; Minvielle, Stephane S; Campbell, Peter J PJ; Papaemmanuil, Elli E; Avet-Loiseau, Herve H; Munshi, Nikhil C NC
Publication Date: 2018-12

Variant appearance in text: TET2: A584V
PubMed Link: 29789651
Variant Present in the following documents:
  • 41375_2018_37_MOESM14_ESM.xlsx, sheet 1
View BVdb publication page